Monday, September 28, 2015 4:01:32 PM
closed hod .41 above .40
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
Recent PHIO News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 11:15:34 AM
- Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762 • Newsfile • 03/30/2026 11:00:00 AM
- Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement • Newsfile • 03/23/2026 11:00:00 AM
- Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office • Newsfile • 03/16/2026 03:30:00 PM
- Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/13/2026 12:35:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th • GlobeNewswire Inc. • 03/10/2026 02:21:44 PM
- Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT • GlobeNewswire Inc. • 03/10/2026 12:35:00 PM
- Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT • GlobeNewswire Inc. • 03/10/2026 11:59:39 AM
- Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT • Newsfile • 03/10/2026 11:00:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2026 09:17:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 09:10:23 PM
- Phio Pharmaceuticals Reports 2025 Year-End Financial Results and Business Update • Newsfile • 03/05/2026 09:05:00 PM
- Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series • Newsfile • 03/05/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 09:01:20 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 07:49:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/10/2026 12:33:55 PM
- Phio Announces Safety Monitoring Committee's (SMC) Positive Wrap-up on Lead Clinical Candidate PH-762 in Skin Cancer Trial • Newsfile • 02/10/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 01:00:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 12:59:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 12:58:27 PM
- Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference • Newsfile • 01/26/2026 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 02:33:00 PM
- Phio Pharmaceuticals Announces Key Tumor Response Data from all Cohorts in Intratumoral PH-762 Dose Escalation Cutaneous Carcinoma Trial • Newsfile • 01/20/2026 02:30:00 PM
- Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026 • Newsfile • 01/15/2026 01:45:00 PM
